Drug Topics

JUNE 9, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

FDA 281

FDA Specialty Pharmacies Compounding Independent Pharmacies 281

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Chemotherapy 65

Chemotherapy Compounding Pharmacies Immunization Hospitals 65

Drug Topics

JUNE 9, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Community Pharmacies 247

Community Pharmacies Immunization Specialty Pharmacies Compounding 247

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Commerce

JUNE 9, 2025

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data & Technology Data &

Vaccines 52

Vaccines Immunization Hospitals Pharmaceutical Companies 52

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

FDA 82

FDA Compounding Pharmacies Immunization Hospitals 82

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 73

Compounding Pharmacies Compounding Immunization FDA 73

Pharmaceutical Commerce

JUNE 9, 2025

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored Nation executive order.

52

52

Pharmacy Times

JUNE 9, 2025

A multidisciplinary team enhances psychiatric care by empowering community pharmacists to administer long-acting injectable antipsychotics, improving patient adherence and outcomes.

73

73

Fierce Pharma

JUNE 9, 2025

The FDA has blessed Merck’s clesrovimab to protect against lower respiratory tract disease related to respiratory syncytial virus in newborns and infants. The monoclonal antibody, which will be known commercially as Enflonsia, will challenge Sanofi and AstraZeneca’s blockbuster Beyfortus.

FDA 73

FDA 73

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

Drug Topics

JUNE 9, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Immunization 471

Immunization Vaccines Independent Pharmacies Specialty Pharmacies 471

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 56

Compounding Pharmacies FDA Hospitals Immunization 56

The Checkup by Singlecare

JUNE 9, 2025

In the last few years, pharmaceutical advancements have led to a new class of drugs that treat Type 2 diabetes and obesity. Known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs or GLP-1s), these medications are incredibly effective for blood sugar control and weight loss. Most GLP-1s are only FDA-approved for use in adults. However, four injectable GLP-1 drugs, Saxenda ( liraglutide ), Wegovy ( semaglutide ), Bydureon BCISE ( exenatide ), and Trulicity ( dulaglutide ), have been approve

FDA 52

FDA Hospitals 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Specialty Pharmacies 65

Drug Topics

JUNE 9, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Compounding 247

Compounding Immunization Vaccines Specialty Pharmacies 247

Pharmacy Times

JUNE 9, 2025

As policy developments unfold rapidly at both the state and federal levels, Tom Kraus highlights the expanding scope of pharmacist practice through a wave of state-level legislation as a key opportunity.

73

73

Pharmaceutical Technology

JUNE 9, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA 52

FDA Communication Hospitals Packaging 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 9, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 73

Compounding Pharmacies Immunization Hospitals Compounding 73

Pharmaceutical Technology

JUNE 9, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmafile

JUNE 9, 2025

Elgan Pharma, specialising in neonatology, and Italy-based biopharma, Chiesi Farmaceutici, have announced the dosing of the first participating infants in FIT-PIV, a phase 3 clinical study of ELGN-2112, a prospective treatment for intestinal malabsorption in preterm infants. The FIT-PIV study is expected to roll 420 infants, born 26-32 weeks and weighing at least 500g, at […] The post Study into treatment for rare condition in premature infants launches globally appeared first on Pharmafil

59

59

pharmaphorum

JUNE 9, 2025

As an FDA decision nears from a rival MSD drug, Sanofi is speeding up the rollout of RSV antibody Beyfortus to get ahead of this year's season

FDA 59

FDA 59

The Checkup by Singlecare

JUNE 9, 2025

Since the discovery of antibiotics in 1928, numerous infection-fighting medicines have hit the market. Many people are familiar with penicillin antibiotics, the first one to be mass-produced, but that’s not your only option. Another popular antibiotic treatment is cephalexin. Cephalexin is a generic drug sometimes sold under the brand names Keflex, Daxbia, or Biocef.

Dosage 52

Dosage Adverse Reactions FDA 52

PharmD Live

JUNE 9, 2025

Chronic disease is the single largest driver of healthcare costs and patient complexity , accounting for nearly 86% of U.S. healthcare spending. As regulatory requirements and value-based care models evolve, the need for robust, compliant, and clinically effective Chronic Care Management (CCM) solutions has never been greater. In 2025, healthcare leaders face a critical choice: selecting a CCM partner that not only meets CMS standards but also drives measurable patient outcomes, operational effi

Documentation 52

Documentation Hospitals 52

Fierce Pharma

JUNE 9, 2025

The drug is the first triple-combo pill for the initial treatment of hypertension in the U.S.

85

85

Pharmacy Times

JUNE 9, 2025

The FDA approves clesrovimab-cfor, a new RSV vaccine, offering infants effective protection against severe respiratory illness during their first RSV season.

FDA 82

FDA Vaccines 82

Pharmafile

JUNE 9, 2025

21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on behalf of the judges, Carrie Kenyon from Finger Industries said: “With an important objective, to guide doctors to a realisation that they may be practising outdated medicine in treating hyperkalaemia, the film itself was brilliantly […] The post The unbearable lightness of creativity appeared first on Pharmafile.

Communication 59

Communication 59

The Checkup by Singlecare

JUNE 9, 2025

People living with overactive bladder (OAB) are often prescribed Gemtesa , an oral tablet approved by the U.S. Food and Drug Administration (FDA) to relieve overactive bladder symptoms such as urinary incontinence. When getting a new prescription, it’s normal to wonder about possible side effects. For instance, does Gemtesa cause weight gain? The answer is no; Gemtesa isn’t associated with weight changes.

Packaging 105

Packaging FDA 105

Pharma Times

JUNE 9, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs PharmaTimes Clinical Researcher of the Year – The Americas by John Pinching | 9th Jun 2025 | News Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!

28

28

pharmaphorum

JUNE 9, 2025

Otsuka and Vera both have new phase 3 data on drugs for kidney disease IgA nephropathy, but can they make a mark in an increasingly crowded market

71

71

PharmaVoice

JUNE 9, 2025

Skip to main content Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Eve

Vaccines 130

Vaccines Immunization 130

Pharmaceutical Commerce

JUNE 9, 2025

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

The Checkup by Singlecare

JUNE 9, 2025

Trintellix ( vortioxetine ) is a brand-name antidepressant in the selective serotonin reuptake inhibitor /5-HT1A receptor partial agonist drug class and is an important contribution to the armamentarium of mental health prescription drugs. It is approved by the Food and Drug Administration ( FDA ) for the management of major depressive disorder ( MDD ).

FDA 52

FDA 52